Home/Filings/4/0001127602-21-008565
4//SEC Filing

Fleming Michael 4

Accession 0001127602-21-008565

CIK 0000310158other

Filed

Mar 1, 7:00 PM ET

Accepted

Mar 2, 11:35 AM ET

Size

4.9 KB

Accession

0001127602-21-008565

Insider Transaction Report

Form 4
Period: 2021-02-26
Fleming Michael
SVP Chief Ethics & Com Officer
Transactions
  • Award

    Common Stock

    2021-02-26$72.62/sh+3,437$249,59510,283.334 total
Footnotes (2)
  • [F1]Distribution of net after tax shares of common stock on satisfaction of performance criteria for performance share units granted on 3/29/18. Performance shares were paid out at 166 percent of target awards. Includes dividends accrued over the three-year performance period ending December 31, 2020.
  • [F2]Holdings include shares acquired in dividend reinvestment transactions.

Issuer

Merck & Co., Inc.

CIK 0000310158

Entity typeother

Related Parties

1
  • filerCIK 0001772183

Filing Metadata

Form type
4
Filed
Mar 1, 7:00 PM ET
Accepted
Mar 2, 11:35 AM ET
Size
4.9 KB